Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study.
Harbeck N, Wrobel D, Zaiss M, Terhaag J, Guth D, Distelrath A, Zahn MO, Wuerstlein R, Lorenz A, Bartsch R, Breitenstein U, Schwitter M, Balic M, Jackisch C, Müller V, Rinnerthaler G, Schmidt M, Zaman K, Schinköthe T, Resch A, Valenti R, Lüftner D. Harbeck N, et al. Among authors: lorenz a. Breast Care (Basel). 2024 Feb;19(1):1-9. doi: 10.1159/000533657. Epub 2023 Oct 5. Breast Care (Basel). 2024. PMID: 38384488
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial.
Harbeck N, Fasching PA, Wuerstlein R, Degenhardt T, Lüftner D, Kates RE, Schumacher J, Räth P, Hoffmann O, Lorenz R, Decker T, Reinisch M, Göhler T, Staib P, Gluz O, Schinköthe T, Schmidt M; AGO-B WSG PreCycle investigators (see Appendix 1). Harbeck N, et al. Among authors: lorenz r. Ann Oncol. 2023 Aug;34(8):660-669. doi: 10.1016/j.annonc.2023.05.003. Epub 2023 May 16. Ann Oncol. 2023. PMID: 37201751 Free article. Clinical Trial.
Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients.
Metz M, Semsek D, Rogmans G, Hutzschenreuter U, Fietz T, Harde J, Zacharias S, Hielscher C, Lorenz A, Zahn MO, Guth D, Liebers S, Berghorn M, Grebhardt S, Matillon CD, Egerer G, Potthoff K. Metz M, et al. Among authors: lorenz a. Support Care Cancer. 2021 Nov;29(11):6633-6643. doi: 10.1007/s00520-021-06230-9. Epub 2021 May 6. Support Care Cancer. 2021. PMID: 33956213 Free PMC article. Clinical Trial.
Differential associations of five riverine organism groups with multiple stressors.
Kaijser W, Lorenz AW, Brauer VS, Burfeid-Castellanos A, David GM, Nuy JK, Baikova D, Beszteri B, Gillmann SM, Kiesel J, Mayombo NAS, Peters K, Rettig K, Rolauffs P, Haase P, Hering D. Kaijser W, et al. Among authors: lorenz aw. Sci Total Environ. 2024 May 14;934:173105. doi: 10.1016/j.scitotenv.2024.173105. Online ahead of print. Sci Total Environ. 2024. PMID: 38750737 Free article.
The Obese Taste Bud study: Objectives and study design.
Kersten A, Lorenz A, Nottmeier C, Schmidt M, Roesner A, Richter FC, Röhrborn K, Witte AV, Hahnel S, Koehne T, Blüher M, Stumvoll M, Rohde-Zimmermann K, Schamarek I. Kersten A, et al. Among authors: lorenz a. Diabetes Obes Metab. 2024 Jun;26(6):2054-2068. doi: 10.1111/dom.15563. Epub 2024 Apr 15. Diabetes Obes Metab. 2024. PMID: 38618969
Pr3+-doped YPO4 nanocrystal embedded into an optical fiber.
Dorosz D, Kochanowicz M, Valiente R, Diego-Rucabado A, Rodríguez F, Siñeriz-Niembro N, Espeso JI, Lesniak M, Miluski P, Conzendorf S, Posseckardt J, Liao Z, Jimenez GL, Müller R, Lorenz M, Schwuchow A, Leich M, Lorenz A, Wondraczek K, Jäger M. Dorosz D, et al. Among authors: lorenz a. Sci Rep. 2024 Mar 28;14(1):7404. doi: 10.1038/s41598-024-57307-4. Sci Rep. 2024. PMID: 38548783 Free PMC article.
461 results